Gland Pharma Limited
GLAND
Clasificación en acciones
#3303
Gland Pharma Limited, established in Hyderabad, India, in 1978, is a... Gland Pharma Limited, established in Hyderabad, India, in 1978, is a pharmaceutical company that specializes in the creation, production, and global distribution of generic injectable medications. Its product line features key active pharmaceutical ingredients such as heparin sodium, enoxaparin sodium, rocuronium bromide, and daptomycin injections, among others. The company's extensive therapeutic portfolio encompasses anti-infectives, anesthetics, anticoagulants, antimalarials, cardiovascular drugs, gastrointestinal treatments, pain management, hormones, fertility aids, anti-cancer agents, gynecological remedies, neurological and central nervous system medications, respiratory treatments, blood-related products, ophthalmological and otological solutions, orthopedics, hematinics, and various vitamins, minerals, and nutrients. Additionally, Gland Pharma provides contract development services. The company primarily operates on a business-to-business (B2B) model, distributing its products across major markets including the United States, Europe, Canada, Australia, India, and other international territories. Gland Pharma Limited functions as a subsidiary of Fosun Pharma Industrial Pte. Ltd.
Precio por acción
$32.32
Capitalización bursátil
$5.33B
Cambio (1 día)
-3.01%
Cambio (1 año)
47.99%
País
IN
Comercio Gland Pharma Limited (GLAND)
Categoría
Healthcare
Ratio P/S de Gland Pharma Limited (GLAND)
Ratio P/S al October 2026 TTM: 7.47
Según los informes financieros más recientes y el precio de las acciones de Gland Pharma Limited, el ratio P/S actual (TTM) es 7.47. Al final de 2024, el ratio P/S era 5.27.
Historial del ratio P/S de Gland Pharma Limited desde 2017 hasta 2026
Ratio P/S al final de cada año
| Año | Ratio P/S | Cambiar |
|---|---|---|
| 2026 (TTM) | 7.47 | 63.72% |
| 2025 | 4.56 | -13.61% |
| 2024 | 5.27 | -9.26% |
| 2023 | 5.81 | -52.56% |
| 2022 | 12.25 | 7.08% |
| 2021 | 11.44 | 4.38% |
| 2020 | 10.96 | -26.45% |
| 2019 | 14.91 | -20.73% |
| 2018 | 18.80 | -1.35% |
| 2017 | 19.06 | 0.00% |
Ratio P/S de empresas similares o competidoras
| Empresa | Ratio P/S | Diferencia del ratio P/S | País |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| 7.06 | -5.46% |
IN
|
